gabapentin has been researched along with Urogenital Prolapse in 2 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gabapentin dosing was 600 mg (<65 years) or 300 mg (>65 years)." | 2.90 | Does low-dose gapapentin reduce opioid use postoperatively?: A randomized controlled trial in women undergoing reconstructive pelvic surgery. ( Alarab, M; Dawood, A; Lemos, N; Li, ALK; Lovatsis, D; McDermott, CD; Siddiqui, NT; Wadsworth, K, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramaseshan, AS | 1 |
| O'Sullivan, DM | 1 |
| Steinberg, AC | 1 |
| Tunitsky-Bitton, E | 1 |
| Li, ALK | 1 |
| Wadsworth, K | 1 |
| Siddiqui, NT | 1 |
| Alarab, M | 1 |
| McDermott, CD | 1 |
| Lemos, N | 1 |
| Dawood, A | 1 |
| Lovatsis, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double-Blind Randomized Placebo-Controlled Clinical Trial of Preoperative Gabapentin Prior to Vaginal Apical Suspension Prolapse Procedures[NCT05658887] | Phase 4 | 110 participants (Anticipated) | Interventional | 2023-01-01 | Enrolling by invitation | ||
| "Gabapentin Reduces Opioid Use Postoperatively (GROUP Study): A Randomized Control Trial in Women Undergoing Reconstructive Pelvic Surgery"[NCT02999724] | Phase 3 | 44 participants (Anticipated) | Interventional | 2017-01-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for gabapentin and Urogenital Prolapse
| Article | Year |
|---|---|
Does low-dose gapapentin reduce opioid use postoperatively?: A randomized controlled trial in women undergoing reconstructive pelvic surgery.
Topics: Adult; Analgesics; Analgesics, Opioid; Combined Modality Therapy; Double-Blind Method; Female; Gabap | 2019 |
Does low-dose gapapentin reduce opioid use postoperatively?: A randomized controlled trial in women undergoing reconstructive pelvic surgery.
Topics: Adult; Analgesics; Analgesics, Opioid; Combined Modality Therapy; Double-Blind Method; Female; Gabap | 2019 |
Does low-dose gapapentin reduce opioid use postoperatively?: A randomized controlled trial in women undergoing reconstructive pelvic surgery.
Topics: Adult; Analgesics; Analgesics, Opioid; Combined Modality Therapy; Double-Blind Method; Female; Gabap | 2019 |
Does low-dose gapapentin reduce opioid use postoperatively?: A randomized controlled trial in women undergoing reconstructive pelvic surgery.
Topics: Adult; Analgesics; Analgesics, Opioid; Combined Modality Therapy; Double-Blind Method; Female; Gabap | 2019 |
1 other study available for gabapentin and Urogenital Prolapse
| Article | Year |
|---|---|
A comprehensive model for pain management in patients undergoing pelvic reconstructive surgery: a prospective clinical practice study.
Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Ste | 2020 |